Fox Chase researchers to use $497K NCI grant to develop platform for testing pancreatic cancer drug therapies

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Researchers at Fox Chase Cancer Center have received a $497,000 multi-year grant from NCI to develop a way to evaluate novel drug therapies in patients with pancreatic cancer.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login